DK1056448T3 - Farmaceutiske kombinationer med tramadol - Google Patents

Farmaceutiske kombinationer med tramadol

Info

Publication number
DK1056448T3
DK1056448T3 DK99916744T DK99916744T DK1056448T3 DK 1056448 T3 DK1056448 T3 DK 1056448T3 DK 99916744 T DK99916744 T DK 99916744T DK 99916744 T DK99916744 T DK 99916744T DK 1056448 T3 DK1056448 T3 DK 1056448T3
Authority
DK
Denmark
Prior art keywords
tramadol
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Application number
DK99916744T
Other languages
Danish (da)
English (en)
Inventor
Helmut Momberger
Marc Raber
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Application granted granted Critical
Publication of DK1056448T3 publication Critical patent/DK1056448T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK99916744T 1998-02-21 1999-02-17 Farmaceutiske kombinationer med tramadol DK1056448T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19807535A DE19807535A1 (de) 1998-02-21 1998-02-21 Pharmazeutische Kombinationen mit Tramadol
PCT/DE1999/000428 WO1999042095A1 (de) 1998-02-21 1999-02-17 Pharmazeutische kombinationen mit tramadol

Publications (1)

Publication Number Publication Date
DK1056448T3 true DK1056448T3 (da) 2004-05-17

Family

ID=7858642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916744T DK1056448T3 (da) 1998-02-21 1999-02-17 Farmaceutiske kombinationer med tramadol

Country Status (26)

Country Link
EP (1) EP1056448B1 (zh)
JP (1) JP2002503689A (zh)
KR (1) KR100567154B1 (zh)
CN (1) CN1141937C (zh)
AR (1) AR018102A1 (zh)
AT (1) ATE257700T1 (zh)
AU (1) AU748993B2 (zh)
BG (1) BG64888B1 (zh)
BR (1) BR9909211A (zh)
CZ (1) CZ291941B6 (zh)
DE (2) DE19807535A1 (zh)
DK (1) DK1056448T3 (zh)
EA (1) EA002166B1 (zh)
ES (1) ES2212549T3 (zh)
HK (1) HK1035143A1 (zh)
HU (1) HU225656B1 (zh)
IL (1) IL137505A (zh)
NO (1) NO327860B1 (zh)
NZ (1) NZ506020A (zh)
PL (1) PL204075B1 (zh)
PT (1) PT1056448E (zh)
SK (1) SK284937B6 (zh)
TR (1) TR200002411T2 (zh)
TW (1) TWI228040B (zh)
WO (1) WO1999042095A1 (zh)
ZA (1) ZA991212B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915873A (pt) * 1998-12-02 2001-08-21 Darwin Discovery Ltd Produto terapêutico e seu uso
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
AU3582101A (en) * 2000-03-01 2001-09-12 Euro-Celtique S.A. The treatment of functional gastrointestinal disorders
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
EP2813144A1 (en) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Analgesic compositions comprising an antihistamine
WO2009089494A2 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions
CN102014625A (zh) 2008-04-28 2011-04-13 佐吉尼克斯股份有限公司 用于治疗偏头痛的新制剂
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
CN106413717A (zh) * 2014-04-10 2017-02-15 查尔斯顿实验室公司 药物组合物
WO2017152130A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
US11517545B2 (en) 2016-12-15 2022-12-06 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis
JP7195660B1 (ja) 2021-09-09 2022-12-26 壽製薬株式会社 口腔内崩壊錠

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2712809B1 (fr) * 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
FR2720936B1 (fr) * 1994-06-08 1997-04-30 Synthelabo Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicylique.
GB9523566D0 (en) * 1995-11-17 1996-01-17 Euro Celtique Sa Pharmaceutical formulation
FR2741532B1 (fr) * 1995-11-28 1998-08-21 Bouchara Sa Nouvelles compositions pharmaceutiques a action antimigraineuse et leur mode de preparation
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Also Published As

Publication number Publication date
WO1999042095A1 (de) 1999-08-26
HU225656B1 (en) 2007-05-29
ZA991212B (en) 1999-08-03
CN1141937C (zh) 2004-03-17
BG64888B1 (bg) 2006-08-31
KR20010041110A (ko) 2001-05-15
TWI228040B (en) 2005-02-21
PL204075B1 (pl) 2009-12-31
AU3514899A (en) 1999-09-06
DE19807535A1 (de) 1999-08-26
NO20004143L (no) 2000-09-27
ES2212549T3 (es) 2004-07-16
NO20004143D0 (no) 2000-08-18
IL137505A (en) 2005-07-25
TR200002411T2 (tr) 2000-12-21
KR100567154B1 (ko) 2006-04-04
AR018102A1 (es) 2001-10-31
AU748993B2 (en) 2002-06-13
HK1035143A1 (en) 2001-11-16
NZ506020A (en) 2002-05-31
CZ291941B6 (cs) 2003-06-18
HUP0100964A3 (en) 2003-09-29
NO327860B1 (no) 2009-10-05
HUP0100964A2 (hu) 2001-08-28
EP1056448B1 (de) 2004-01-14
DE59908305D1 (de) 2004-02-19
IL137505A0 (en) 2001-07-24
BR9909211A (pt) 2000-11-14
ATE257700T1 (de) 2004-01-15
CZ20002939A3 (cs) 2000-12-13
EA200000862A1 (ru) 2001-02-26
JP2002503689A (ja) 2002-02-05
PL342546A1 (en) 2001-06-18
SK284937B6 (sk) 2006-02-02
PT1056448E (pt) 2004-05-31
BG104758A (en) 2001-04-30
EP1056448A1 (de) 2000-12-06
EA002166B1 (ru) 2001-12-24
CN1291092A (zh) 2001-04-11
SK12172000A3 (sk) 2001-04-09

Similar Documents

Publication Publication Date Title
DK1025241T4 (da) Protease-varianter med mangfoldige substitutioner
ID27415A (id) Komposisi farmaseutik
DE60009395D1 (de) Bildanzeige
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
ID23076A (id) Popok sekali pakai
ATE341990T1 (de) Sigmidoskop
ID27841A (id) Turunan-turunan biaril terapeutik
ID29089A (id) Sediaan farmasi moksifloksasin
ID29262A (id) Komposisi farmasi
DK1466615T3 (da) Farmaceutisk præparat
ID23083A (id) Popok sekali pakai
DK1056448T3 (da) Farmaceutiske kombinationer med tramadol
ID27201A (id) Komposisi farmasi
ATE262513T1 (de) Benzoylpyridazine
DE19842103B4 (de) Stanznietzuführung
DK1051156T3 (da) Farmaceutiske præparater
FI980856A0 (fi) Andningsskydd utrustad med en identifierare
IS5877A (is) Ný efnablanda
IS5879A (is) Ný efnablanda
SE9801216D0 (sv) Pharmaceuticals
ID26084A (id) Turunan-turunan amino antrasiklinon
DE29809642U1 (de) Mürbehammer
DE29802605U1 (de) Etagère
FI980596A0 (fi) Koerljussystem med blaendskyddsanordning